1. Home
  2. JPC vs TWST Comparison

JPC vs TWST Comparison

Compare JPC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JPC
  • TWST
  • Stock Information
  • Founded
  • JPC 2003
  • TWST 2013
  • Country
  • JPC United States
  • TWST United States
  • Employees
  • JPC N/A
  • TWST N/A
  • Industry
  • JPC Investment Managers
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JPC Finance
  • TWST Health Care
  • Exchange
  • JPC Nasdaq
  • TWST Nasdaq
  • Market Cap
  • JPC 2.5B
  • TWST 2.3B
  • IPO Year
  • JPC N/A
  • TWST 2018
  • Fundamental
  • Price
  • JPC $8.08
  • TWST $33.68
  • Analyst Decision
  • JPC
  • TWST Buy
  • Analyst Count
  • JPC 0
  • TWST 10
  • Target Price
  • JPC N/A
  • TWST $49.10
  • AVG Volume (30 Days)
  • JPC 998.5K
  • TWST 960.3K
  • Earning Date
  • JPC 01-01-0001
  • TWST 08-04-2025
  • Dividend Yield
  • JPC 7.57%
  • TWST N/A
  • EPS Growth
  • JPC N/A
  • TWST N/A
  • EPS
  • JPC N/A
  • TWST N/A
  • Revenue
  • JPC N/A
  • TWST $347,680,000.00
  • Revenue This Year
  • JPC N/A
  • TWST $22.75
  • Revenue Next Year
  • JPC N/A
  • TWST $17.74
  • P/E Ratio
  • JPC N/A
  • TWST N/A
  • Revenue Growth
  • JPC N/A
  • TWST 25.30
  • 52 Week Low
  • JPC $5.94
  • TWST $27.12
  • 52 Week High
  • JPC $7.36
  • TWST $56.84
  • Technical
  • Relative Strength Index (RSI)
  • JPC 56.12
  • TWST 41.75
  • Support Level
  • JPC $8.03
  • TWST $34.25
  • Resistance Level
  • JPC $8.18
  • TWST $37.12
  • Average True Range (ATR)
  • JPC 0.04
  • TWST 1.69
  • MACD
  • JPC -0.01
  • TWST -0.40
  • Stochastic Oscillator
  • JPC 80.77
  • TWST 20.90

About JPC Nuveen Preferred & Income Opportunities Fund

Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: